Matthew T. McMillan
University of Pennsylvania
Framingham Risk ScoreInterquartile rangeCancerRisk assessmentInternal medicineSurgeryOncologyRetrospective cohort studyHazard ratioSurvival rateFistulaAdjuvant therapyPancreaticoduodenectomyMEDLINEPancreatic fistulaProportional hazards modelRadiation therapyGeneral surgeryMedicineComplication
76Publications
25H-index
1,566Citations
Publications 75
Newest
#1Matthew T. McMillan (UPenn: University of Pennsylvania)H-Index: 25
#2Giuseppe MalleoH-Index: 46
Last. Charles M. VollmerH-Index: 67
view all 13 authors...
Objective:This multicenter study sought to prospectively evaluate a drain management protocol for pancreatoduodenectomy (PD).Background:Recent evidence suggests value for both selective drain placement and early drain removal for PD. Both strategies have been associated with reduced rates of clinica
Source
#1Brett L. EckerH-Index: 19
#2Matthew T. McMillanH-Index: 25
Last. Robert E. RosesH-Index: 34
view all 9 authors...
BACKGROUND To the authors' knowledge, optimal adjuvant approaches for resected duodenal adenocarcinoma are not well established. Given the significant risk of locoregional disease recurrence, there may be a subset of patients who demonstrate an improvement in overall survival (OS) from the addition of radiotherapy (chemoradiotherapy [CRT]) to an adjuvant chemotherapy regimen. METHODS Patients with resected, nonmetastatic duodenal adenocarcinoma who received chemotherapy (694 patients) or CRT (55...
Source
#1Matthew T. McMillan (UPenn: University of Pennsylvania)H-Index: 25
#2Valentina Allegrini (University of Verona)H-Index: 12
Last. Charles M. Vollmer (UPenn: University of Pennsylvania)H-Index: 67
view all 35 authors...
Objective:This multicenter study sought to evaluate the accuracy of the American College of Surgeons National Surgical Quality Improvement Program's (ACS-NSQIP) surgical risk calculator for predicting outcomes after pancreatoduodenectomy (PD) and to determine whether incorporating other factors impr
Source
#1Matthew T. McMillan (UPenn: University of Pennsylvania)H-Index: 25
#2Amer H. Zureikat (University of Pittsburgh)H-Index: 44
Last. Charles M. Vollmer (UPenn: University of Pennsylvania)H-Index: 67
view all 7 authors...
Importance The adoption of robotic pancreatoduodenectomy (RPD) is gaining momentum; however, its impact on major outcomes, including pancreatic fistula, has yet to be adequately compared with open pancreatoduodenectomy (OPD). Objective To demonstrate that use of RPD does not increase the incidence of clinically relevant pancreatic fistula (CR-POPF) compared with OPD. Design, Setting, and Participants Data were accrued from 2846 patients who underwent pancreatoduodenectomies (OPDs, n = 2661; RPDs...
Source
#1Brett L. EckerH-Index: 19
#2Matthew T. McMillanH-Index: 25
Last. Charles M. VollmerH-Index: 67
view all 3 authors...
Source
#1Brett L. EckerH-Index: 19
#2Matthew T. McMillanH-Index: 25
Last. Charles M. VollmerH-Index: 67
view all 4 authors...
Source
#1Matthew T. McMillanH-Index: 25
#2Laura MagginoH-Index: 17
Last. Charles M. VollmerH-Index: 67
view all 4 authors...
Source
#1Daniel E. Abbott (UW: University of Wisconsin-Madison)H-Index: 14
#2Ching Wei D. Tzeng (University of Texas MD Anderson Cancer Center)H-Index: 34
Last. Charles M. Vollmer (UPenn: University of Pennsylvania)H-Index: 67
view all 11 authors...
Abstract Background As payment models evolve, disease-specific risk stratification may impact patient selection and financial outcomes. This study sought to determine whether a validated clinical risk score for post-operative pancreatic fistula (POPF) could predict hospital costs, payments, and profit margins. Methods A multi-institutional cohort of 1193 patients undergoing pancreaticoduodenectomy (PD) were matched to an independent hospital where cost, in US$, and payment data existed. An analy...
Source
#1Brett L. Ecker (UPenn: University of Pennsylvania)H-Index: 19
#2Madalyn G. Peters (UPenn: University of Pennsylvania)H-Index: 4
Last. Giorgos C. Karakousis (UPenn: University of Pennsylvania)H-Index: 42
view all 10 authors...
Background The rate of lymph node (LN) metastasis is rare in soft tissue sarcoma, but there are histologic subtypes that metastasize via the lymphatics. The prognostic value of LN evaluation in these high-risk histologies is unknown.
Source
#1Vivek Verma (UNMC: University of Nebraska Medical Center)H-Index: 38
#2Matthew T. McMillan (HUP: Hospital of the University of Pennsylvania)H-Index: 25
Last. Charles B. Simone (HUP: Hospital of the University of Pennsylvania)H-Index: 54
view all 4 authors...
Purpose Stereotactic body radiation therapy (SBRT) for ≥5 cm lesions is poorly defined, largely owing to the low sample sizes in existing studies. The present analysis examined the SBRT outcomes and assessed the effect of chemotherapy in this population. Methods and Materials The National Cancer Data Base was queried for primary non-small cell lung cancer ≥5 cm treated with SBRT (≤10 fractions). Patient, tumor, and treatment parameters were extracted. The primary outcome was overall survival (OS...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.